DrugPatentWatch: Pharmaceutical Patent Intelligence Software
DrugPatentWatch helps pharmaceutical companies and legal professionals track patent expirations and generic entry. It is designed for teams that need to monitor loss-of-exclusivity dates and competitive landscapes.
At a glance
- Category
- Data & Analytics
- Best for
- Pharmaceutical companies, Biotech companies, Law firms, Pharmaceutical researchers, Business intelligence teams
- Pricing
- Subscription plans start at $1,000 per month for the Starter tier. The Professional tier is $3,000 per month and includes AI features, while Enterprise pricing is custom. A limited one-month all-access offer is available for $499 until April 8th, 2026.
- Key use cases
- Identifying Generic Entry Opportunities, Biosimilar Activity Monitoring, Competitive Intelligence, Supply Chain Sourcing, Market-Entry Strategy
- Integrations
- Data export (Professional/Enterprise plans)
- Official website
- drugpatentwatch.com
DrugPatentWatch is a business intelligence platform for the biopharmaceutical sector. It provides a database of active and expired patents for small-molecule drugs in 134 countries, which helps users monitor regulatory protections and exclusivity statuses.
The tool is designed for pharmaceutical and biotech companies, law firms, and researchers. It supports workflows related to drug lifecycle management by tracking patent challenges, tentative approvals, and the entry of generic and biosimilar competitors.
In addition to database access, the platform includes an AI Research Assistant and a Deep Research Engine to answer queries. Users can also access drug sales data, pricing information, and litigation histories to help inform market-entry strategies.
Buyers should confirm their specific needs regarding subscription tiers, as the Starter plan has limits on searches and does not support data export, while AI features are available in higher-tier plans.
Key Features
Provides data on active and expired patents across 134 countries.
Tracks exclusivity expiration dates, Paragraph IV challenges, and tentative approvals.
Provides cited answers to queries that may extend beyond the primary database scope.
Designed to aggregate information from disparate sources for in-depth analysis.
Includes drug sales figures, brand versus generic price gaps, and annual gross revenues.
Monitors US District Court cases and Patent Trial and Appeal Board (PTAB) reviews.
Supports the automation of reporting processes to help reduce manual workload.
Use Cases
Monitoring patent expirations and loss-of-exclusivity dates to identify when generic versions of a drug may enter the market.
Tracking the development and clinical trial progress of biosimilars and 505(b)(2) drug pathways.
Analyzing competitor NDAs, patents, and litigation history to help anticipate market moves.
Identifying API vendors and finished product suppliers for specific drug ingredients.
Using historical sales and price range data to evaluate market potential and help set launch prices.
Best For
Integrations
Pricing
Subscription plans start at $1,000 per month for the Starter tier. The Professional tier is $3,000 per month and includes AI features, while Enterprise pricing is custom. A limited one-month all-access offer is available for $499 until April 8th, 2026.
FAQ
It provides data on active and expired drug patents in 134 countries, including loss-of-exclusivity dates, drug sales, pricing, and litigation information.
The platform is designed for pharmaceutical and biotech companies, legal professionals, researchers, and business intelligence teams.
Yes, it includes an AI Research Assistant and a Deep Research Engine to help users find cited answers to queries beyond the primary database.
Buyers needing data export capabilities should consider the Professional or Enterprise plans, as the Starter tier does not support data export.
Source category: Data & Analytics
Source subcategory: Business Intelligence
